Hulskof schreef op 23 juni 2021 22:16:
Genetic medicines promise to treat the root cause of disease. When it comes to gene silencing applications, most discussions turn to CRISPR gene editing (knockouts), but RNAi might prove difficult to dislodge. $ALNY $ARWR $NTLAt.co/eCdKH3bdet
Well said and dead-on - exactly why #CRSPR is at least a decade+ away. #RNAi is not only much easier to develop a drug target for, but also quicker, safer, simpler, as effective, easier to manufacture, more stable, and most importantly, it is temporary. $ARWR $ALNY $DRNA
There is no way to UNCRISP someone once they have bene CRISPED!
All of the above and one more point to add. We can’t even get 40% of the US population to take a vaccine for a pandemic virus where the data is pretty clear cut. Those people will not be interested in having their genes edited, especially if a less permanent option is available.
Die laatste vind ik niet onbelangrijk en geeft rnai volgens mij een grote voorsprong.